Homologous recombination repair gene mutation (HRRm) testing patterns and treatment selection from a real-world cohort of patients with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Shore, Neal D.
Craver, Christopher
Blanc, Simon
Sathyan, Pratheesh
Aton, Lindsay
Varughese, Prateesh
Tierno, Marni Brisson
机构：
[1] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[2] Integra Connect, W Palm Beach, FL USA
[3] Integra Connect PrecisionQ, W Palm Beach, FL USA
[4] Illumina Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-5577-2829-12292; 613-225-3248-9542-9243; 130-544; 613-4678-416-5229; 298-11050; 3282-206-4957-326-2356-4994; 9; 7; 6; 3; 2; 109; 1; 38092-20446; 38092-18438; 38092-35367; 38092-20212; 38092-18853;
D O I：
10.1200/JCO.2024.42.4_suppl.210
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [41] Patient reported outcomes (PROs) among patients with metastatic castration-resistant prostate cancer (mCRPC) by homologous recombination repair mutations (HRRm) gene clusters: Findings from the phase 3 TALAPRO-2 study cohort 2.
    Fizazi, Karim
    Shore, Neal D.
    Fong, Peter C. C.
    Azad, Arun
    Matsubara, Nobuaki
    Saad, Fred
    De Giorgi, Ugo
    Joung, Jae Young
    Jones, Robert J.
    Zschaebitz, Stefanie
    Oldenburg, Jan
    Dunshee, Curtis
    Carles, Joan
    Fay, Andre P.
    Cislo, Paul
    Kirker, Melissa
    Healy, Cynthia G.
    Niyazov, Alexander
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 109 - 109
  • [42] Real-world analysis of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving vs not receiving chemotherapy in the treatment sequence
    Morgans, A. K.
    Divan, H. A.
    Birtle, A. J.
    Dorff, T.
    Ozatilgan, A.
    Graff, J. N.
    ANNALS OF ONCOLOGY, 2019, 30 : 334 - 334
  • [43] Real-world treatment with abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC) patients in the post-chemotherapy setting in Europe
    Dearden, L.
    Musingarimi, P.
    Shalet, N.
    Demuth, D.
    Alvarez, L. Garcia
    Muthutantri, A.
    Venerus, A.
    Lasry, R.
    Hankins, M.
    Maher, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S490 - S491
  • [44] Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide
    Scailteux, Lucie-Marie
    Vincendeau, Sebastien
    Gravis, Gwenaelle
    Mathieu, Romain
    Balusson, Frederic
    Kerbrat, Sandrine
    Oger, Emmanuel
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : E362 - E369
  • [45] Real-world treatment patterns in patients diagnosed with metastatic castration-resistant prostate cancer in the US, 2018-2023.
    Efstathiou, Eleni
    Li, Weiyan
    Roose, James
    Kerr, Brendan T.
    Orji, Chinelo
    Yeh, Nina
    Corson, Stephen
    Mukherjee, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [46] BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone plus olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) bearing homologous recombination-repair mutations (HRRm)
    Hussain, Maha H. A.
    Kocherginsky, Masha
    Agarwal, Neeraj
    Adra, Nabil
    Zhang, Jingsong
    Paller, Channing Judith
    Picus, Joel
    Reichert, Zachery R.
    Szmulewitz, Russell Zelig
    Tagawa, Scott T.
    Kuzel, Timothy
    Bazzi, Latifa
    Daignault-Newton, Stephanie
    Whang, Young E.
    Dreicer, Robert
    Stephenson, Ryan D.
    Rettig, Matthew
    Shevrin, Daniel
    Chinnaiyan, Arul
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 19 - 19
  • [47] Real world treatment utilization patterns in patients with castration-resistant prostate cancer
    Vigneswaran, Hari T.
    Warnqvist, Anna
    Andersson, Therese M. L.
    Leval, Amy
    Eklund, Martin
    Nordstrom, Tobias
    Eloranta, Sandra
    Schain, Frida
    Dearden, Lindsay
    Liwing, Johan
    Mehra, Maneesha
    Nair, Sandhya
    Pettersson, Andreas
    Akre, Olof
    Aly, Markus
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (04) : 299 - 306
  • [48] First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry
    Galli, Luca
    Chiuri, Vincenzo Emanuele
    Di Lorenzo, Giuseppe
    Pisconti, Salvatore
    Rossetti, Sabrina
    Sirotova, Zuzana
    Muto, Andrea
    Petrioli, Roberto
    De Tursi, Michele
    Sbrana, Andrea
    Francolini, Giulio
    Ardizzoia, Antonio
    Scavelli, Claudio
    Satta, Francesco
    Quadrini, Silvia
    Airoldi, Mario
    D'Aniello, Carmine
    Bonetti, Andrea
    Conforti, Serafino
    Aieta, Michele
    Beccaglia, Patrizia
    Maestri, Antonio
    Fratino, Lucia
    TUMORI JOURNAL, 2023, 109 (02): : 224 - 232
  • [49] Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Rachel Evans
    Neil Hawkins
    Pascale Dequen-O’Byrne
    Charles McCrea
    Dominic Muston
    Christopher Gresty
    Sameer R. Ghate
    Lin Fan
    Robert Hettle
    Keith R. Abrams
    Johann de Bono
    Maha Hussain
    Neeraj Agarwal
    Targeted Oncology, 2021, 16 : 613 - 623
  • [50] Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Evans, Rachel
    Hawkins, Neil
    Dequen-O'Byrne, Pascale
    McCrea, Charles
    Muston, Dominic
    Gresty, Christopher
    Ghate, Sameer R.
    Fan, Lin
    Hettle, Robert
    Abrams, Keith R.
    de Bono, Johann
    Hussain, Maha
    Agarwal, Neeraj
    TARGETED ONCOLOGY, 2021, 16 (05) : 613 - 623
12345